Funding for this research was provided by:
National Natural Science Foundation of China (No.81803638, No.81422052, No.81673518)
National Key R&D Program of China (No.2017YFC0909302)
Clinical Research Foundation of Xiangya Hospital (No.2016L04)
Text and Data Mining valid from 2019-07-10
Received: 28 February 2019
Accepted: 21 June 2019
First Online: 10 July 2019
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Institute of Clinical Pharmacology, Central South University (Registration Number: CTXY-120025-2) and Chinese Clinical Trial Register (Registration Number: ChiCTR-PPC-14005297). Written informed consent was obtained from all patients or their family members.
: Not applicable.
: The authors declare that they have no competing interests.